The changes in the activity of the pituitary-gonadal axis during sympathetic nerve degeneration after superior cervical ganglionectomy (SCGx) were examined in female rats. In a first experiment SCGx performed at 24.00 h of diestrus II, 17 h in advance to the critical period for gonadotropin and prolactin (PRL) release, caused a delay of 1 day or more in estrous cyclicity, while SCGx at 24.00 h on estrus did not modify the estrous cycle. In a second experiment ovariectomized rats injected subcuta-neously with estradiol-progesterone or vehicle were subjected to SCGx 17 h before the expected maxima in luteinizing hormone (LH), follicle-stimulating hormone (FSH), and PRL serum levels. A significant decrease of serum gonadotropin and PRL concentration was found in SCGx, steroid-treated rats. In a third experiment groups of rats injected with estradiol-progesterone and killed at 15.00, 16.00, 17.00, or 18.00 h at or around the time of maximal FSH, LH, and PRL release were used. SCGx performed 17 h before killing caused a generally depressive effect of LH, FSH, and PRL release. In a fourth experiment ovariectomized rats were subjected to pinealectomy and, 1 week later, to estradiol-progesterone treatment and SCGx as in experiment 2. Pinealectomy did not modify the depression of steroid-induced LH, FSH, and PRL release found during wallerian degeneration of sympathetic nerves after SCGx. In a fifth experiment the effect of α1- and/or β-adrenoceptor blockade on SCGx-induced inhibition of hormone release was assessed in estradiol-progesterone treated, spayed rats. During anterograde degeneration (i.e., 17 h after SCGx) injection of the α1-adrenergic blocker prazosin counteracted the impaired release of LH, FSH, and PRL, while β-adrenoceptor blockade by giving propranolol did not modify hormone secretion. In a sixth experiment groups of rats injected with estradiol-progesterone and killed at 16.00, 17.00, or 18.00 h were subjected to SCGx 17 h before killing, the rats received prazosin or the α1/α2-adrenoceptor blocker phentolamine 45 min before sacrifice. Both drugs were found to be equipotent in counteracting the SCGx effect on gonadotropin and PRL release. These results demonstrate that the coincidence of anterograde degeneration of sympathetic terminals in the superior cervical ganglion field of projection with the spontaneous or induced gonadotropin and PRL release in female rats (1) disrupts temporarily estrous cyclicity and (2) decreases estradiol-progesterone-induced LH, FSH, and PRL release through a pineal gland independent mechanism. Noradrenergic transmitter release from degenerating sympathetic nerves acts via α1-adrenoceptors to decrease gonadotropin and PRL secretion.